UNSPSC 51384801: Droxicam

This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula C16H11N3O5S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier F24ADO1E2D, chemically known as 5-methyl-3-(2-pyridyl)-2h,5h-1,3-oxazino(5,6-c)(1,2)benzothiazine-2,4(3h)-dione 6,6-dioxide but generally known as droxicam, which bears US NIH Compound Identifier 65679. European Medicines Agency schedules Droxicam in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06419MIG.

UNSPSC 51384801 Droxicam, a Commodity code, nominally encompasses a specific nonsteroidal anti-inflammatory drug, yet recent state and local procurement activity under this code shows little alignment with its pharmaceutical scope. The single recent opportunity tagged to this code—Seminole County, Florida's IFB60459723LAS—solicits naloxone and drug deactivation systems for community health purposes, not droxicam or related pharmaceuticals. The mismatch suggests either a data-entry error in code assignment or a state and local procurement system using the code for broader health and emergency-preparedness consumables beyond its nominal definition.

Seminole County's IFB, posted June 30, 2026 with a response deadline of July 26, 2023, seeks 1,900 units of naloxone and 800 safe drug deactivation systems annually, with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. The contract terms include a two-year initial period with a one-year renewal option, fixed-fee pricing, E-Verify compliance, and standard insurance and drug-free workplace certifications. Potential FEMA funding introduces additional federal compliance obligations. No other recent opportunities under this code are present in the source; activity under 51384801 appears limited to this single Seminole County solicitation.